Team Science conducted the ROVER study, which seeks to evaluate the safety and immunogenicity of a booster mRNA vaccine for COVID-19 variants in participants from 6 months to 5 years of age. This study sought to obtain more information about whether the vaccine is safe when administered to infants and children at the same dose as the initial vaccination and how the immune response is when given as a booster.
